The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readings.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/28223

Title:	The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readings.
Authors:	Riera, Joan Hyttel-Sorensen, Simon Bravo, María Carmen Cabañas, Fernando López-Ortego, Paloma Sanchez, Laura Ybarra, Marta Dempsey, Eugene Greisen, Gorm Austin, Topun Claris, Olivier Fumagalli, Monica Gluud, Christian Lemmers, Petra Pichler, Gerhard Plomgaard, Anne Mette van Bel, Frank Wolf, Martin Pellicer, Adelina View more
Keywords:	Intensive Care Monitoring Neonatology View more
Mesh:	Brain Early Medical Intervention Female Humans Infant, Extremely Premature Infant, Newborn Male Monitoring, Physiologic Spectroscopy, Near-Infrared Treatment Outcome Hypoxia, Brain Oxygen Consumption View more
Issue Date:	Jul-2016
Citation:	Arch. Dis. Child. Fetal Neonatal Ed..2016 Jul;(101)4:F333-8
Abstract:	The SafeBoosC phase II randomised clinical trial recently demonstrated the benefits of a combination of cerebral regional tissue oxygen saturation (rStO2) by near-infrared spectroscopy (NIRS) and a treatment guideline to reduce the oxygen imbalance in extremely preterm infants.
PMID:	26645538
URI:	https://hdl.handle.net/20.500.12530/28223
Rights:	openAccess
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos Hospitales > H. U. La Paz > Artículos

Files in This Item:

File	Description	Size	Format
PMC4941140.pdf		818.19 kB	Adobe PDF	View/Open